This is Impax’s first drug to be approved following its Sept. 4 resolution of issues outlined by the FDA in a warning letter to the company.
A new CVS Health Research Insitute study, done in partnership with Brigham and Women’s Hospital, is offering insight into the reasons many patients don’t adhere to their medication regimen.
In July, Stichting Preferred Shares Mylan exercised its full call option on over 488,000,000 preferred shares in Mylan — a move aimed at fending off Teva’s since abandoned attempt at acquiring the pharmaceutical company.
The Centers for Disease Control and prevention this week announced that a new draft guideline for prescribing opioids to patients with chronic pain was in the works.
Mylan on Friday launched its generic version of Lescol XL (fluvastatin sodium) extended-release tablets.
Overall, CDC estimates that 47% of the U.S. population age 6 months and older was vaccinated during the 2014-2015 season, similar to the 2013-2014 season and up from an estimated 41% five years ago.
McKesson on Friday bought the pharmaceutical distribution division of Ireland's UDG Healthcare in a cash transaction valued at $466.5 million.
Aurobindo Pharma’s received approval from the Food and Drug Administration this week for its generic of Roxane Laboratories’ Dolophine (methadone HCL) tablets.